DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for ChemoCentryx, Inc. (CCXI)
« Back to company indexCCXI Chatter Timeline
Stock Ticker for CCXI
Most Active Tweeters for CCXI
| User | Tweets |
|---|---|
| @AmericanBanking | 5 |
| @thefinreviewer | 5 |
| @BlogYomi | 5 |
| @OlympiaReport | 4 |
| @bulletin_en | 4 |
Recent Tweets for CCXI
 |
@UlmHi Nabriva Therapeutics plc $CCXI Comparison side by side https://t.co/iEAFTBeFAN March 21st 2019, 10:03pm |
 |
@thefinreviewer Reviewing Alector Inc. $CCXI's results https://t.co/fAUKPun4AD March 21st 2019, 10:03pm |
|
@thefinreviewer ChemoCentryx, Inc. $CCXI Reaches $10.66 After 6.00% Down Move; Flushing Financial Has 1.03 Sentiment https://t.co/UnYVhm8tr4 March 21st 2019, 2:03pm |
 |
@dakotafinancial ChemoCentryx $CCXI Downgraded by TheStreet https://t.co/pdSoviJj9I March 21st 2019, 1:03am |
|
@thefinreviewer Ionis Pharmaceuticals Inc. $CCXI Comparing side by side https://t.co/TUbJy9eOEu March 20th 2019, 5:03pm |
 |
@TickerReport ChemoCentryx $CCXI Rating Lowered to D- at TheStreet https://t.co/oEVWNF9gCU March 20th 2019, 1:03pm |
 |
@dailypoliticaln ChemoCentryx $CCXI Cut to “D-” at TheStreet https://t.co/Cr6kqGBOAu March 20th 2019, 1:03pm |
 |
@SwingTradeBot $CCXI technical alerts: Pocket Pivot, Expansion Pivot Buy Setup, Volume Surge, 200 DMA Resistance... https://t.co/gtipIFvWaA March 20th 2019, 8:03am |
 |
@macondailynews ChemoCentryx $CCXI Lowered to “D-” at TheStreet https://t.co/o1xhbitlhu March 20th 2019, 7:03am |
 |
@TheMarketsDaily ChemoCentryx $CCXI Lowered to “D-” at TheStreet https://t.co/FCoCSuZdHY March 20th 2019, 7:03am |
 |
@mhrob RT @jdcaetano: $CCXI Yesterday and Today .... someone / or a group is stepping into $CCXI in a very big way. We almost NEVER see vol li… March 19th 2019, 5:03pm |
 |
@whatsonthorold2 What's Propelling ChemoCentryx, Inc. $CCXI to Increase So Much? https://t.co/sro4X9U5nn March 19th 2019, 2:03pm |
 |
@reurope_stock Does ChemoCentryx, Inc. $CCXI Have Any Gas After Today's Significant Increase? https://t.co/ozOozzj45O March 19th 2019, 2:03pm |
 |
@DeepSouthDoctor $CCXI trading up sharply on 6x avg. daily volume. Still love the stock at these levels, very bullish on Ph3 trial f… https://t.co/ugLcmQDT3Z March 19th 2019, 1:03pm |
 |
@BioPharmaWolf Volume in $CCXI has been way higher than average the past couple day, somebody is building a position :) March 19th 2019, 1:03pm |
 |
@jdcaetano $CCXI Yesterday and Today .... someone / or a group is stepping into $CCXI in a very big way. We almost NEVER s… https://t.co/lwN2QwfEb8 March 19th 2019, 12:03pm |
 |
@SmartMoney905 $ccxi pre market bids looking fantastic ?? ? March 19th 2019, 7:03am |
 |
@bulletin_en Weekly ChemoCentryx, Inc. $CCXI Ratings as of Mar 19, 2019 https://t.co/rnbr6SJK2p March 19th 2019, 7:03am |
 |
@ZolmaxNews Zacks Investment Research Downgrades ChemoCentryx $CCXI to Hold https://t.co/ak8sLnR8je March 19th 2019, 3:03am |
 |
@WatchlistN Zacks Investment Research Downgrades ChemoCentryx $CCXI to Hold https://t.co/bd5F2eoPeK March 19th 2019, 3:03am |
|
@WatchlistN ChemoCentryx $CCXI Sees Unusually-High Trading Volume https://t.co/GAYRX8Tj7G March 18th 2019, 11:03pm |
|
@BioPharmaWolf A positive HS readout for $IFRX should be a good thing for $CCXI as well https://t.co/UkOzIAWQll March 18th 2019, 5:03pm |
 |
@ConsumerFeed $11.37 Million in Sales Expected for ChemoCentryx Inc $CCXI This Quarter https://t.co/DT0gHVEkkq March 18th 2019, 4:03pm |
|
@UlmHi As Chemocentryx $CCXI Stock Rose, Shareholder P-A-W Capital Has Lowered Its Position by $400,000; Truenorth Cut Pos… https://t.co/7K4SY2osXf March 18th 2019, 6:03am |
 |
@WeekHerald ChemoCentryx $CCXI Stock Rating Lowered by Zacks Investment Research https://t.co/LVXQGKDOO3 March 18th 2019, 3:03am |
 |
@OlympiaReport Zacks Investment Research Lowers ChemoCentryx $CCXI to Hold https://t.co/uMIdrTTvaY March 18th 2019, 3:03am |
 |
@mmahotstuff1 Are Analysts Bullish ChemoCentryx, Inc. $CCXI After Last Week? https://t.co/1URGwDFqzG March 17th 2019, 2:03pm |
 |
@bibeypost_stock How Many ChemoCentryx, Inc. $CCXI's Analysts Are Bullish? https://t.co/0K1bdd9fvk March 17th 2019, 2:03pm |
 |
@stocknewstimes Zacks Investment Research Upgrades ChemoCentryx $CCXI to Buy https://t.co/mxJj7bPBcK March 17th 2019, 11:03am |
 |
@TranscriptDaily Zacks Investment Research Downgrades ChemoCentryx $CCXI to Hold https://t.co/8YD20CQ95A March 17th 2019, 9:03am |
 |
@HeadlinesFin Reviewing Cleveland BioLabs Inc. $CCXI's results https://t.co/0KjpEfArSo March 16th 2019, 10:03pm |
|
@thefinreviewer TG Therapeutics Inc. $CCXI Contrasting side by side https://t.co/UtFCtL0Qlh March 16th 2019, 9:03pm |
|
@dailypoliticaln ChemoCentryx Inc $CCXI Expected to Post Quarterly Sales of $11.37 Million https://t.co/B2kyIsPoIL March 16th 2019, 9:03pm |
|
@ZolmaxNews Zacks: Analysts Anticipate ChemoCentryx Inc $CCXI Will Announce Quarterly Sales of $11.37 Million https://t.co/GVKJqT6zsX March 16th 2019, 9:03pm |
 |
@bbnsnews ChemoCentryx $CCXI Upgraded at Zacks Investment Research https://t.co/YEw4I4M9bE March 16th 2019, 7:03pm |
 |
@BlogYomi Comparing of Clementia Pharmaceuticals Inc. $CCXI https://t.co/MthSXtVl3k March 16th 2019, 5:03pm |
 |
@dispatchtribune Q1 2019 EPS Estimates for ChemoCentryx Inc $CCXI Raised by Analyst https://t.co/E8SelUYQ1S March 16th 2019, 3:03am |
|
@BlogYomi Contrasting of Alkermes plc $CCXI https://t.co/8PzfzVGAe0 March 16th 2019, 1:03am |
|
@dakotafinancial ChemoCentryx $CCXI Stock Rating Lowered by Zacks Investment Research https://t.co/QxMCHyFkOt March 15th 2019, 7:03pm |
|
@macondailynews ChemoCentryx $CCXI Stock Rating Lowered by Zacks Investment Research https://t.co/ffpstlifKc March 15th 2019, 7:03pm |
|
@TranscriptDaily Zacks Investment Research Upgrades ChemoCentryx $CCXI to Buy https://t.co/zQMBQ8qJQ2 March 15th 2019, 2:03am |
|
@dispatchtribune ChemoCentryx $CCXI Upgraded at Zacks Investment Research https://t.co/rrcGUBzsca March 15th 2019, 1:03am |
|
@BlogYomi Reviewing Oncolytics Biotech Inc. $CCXI's results https://t.co/rcxvnSVOpU March 14th 2019, 8:03pm |
|
@dakotafinancial ChemoCentryx Inc $CCXI Given Consensus Recommendation of “Buy” by Analysts https://t.co/Gu2sK7hIe1 March 14th 2019, 5:03pm |
|
@OlympiaReport -$0.24 EPS Expected for ChemoCentryx Inc $CCXI This Quarter https://t.co/0URXY3QTC5 March 14th 2019, 2:03pm |
|
@dispatchtribune -$0.24 EPS Expected for ChemoCentryx Inc $CCXI This Quarter https://t.co/gD7apxl28I March 14th 2019, 2:03pm |
 |
@registrarjourn ChemoCentryx $CCXI Upgraded at Zacks Investment Research https://t.co/vG0GPCHhs0 March 14th 2019, 12:03pm |
 |
@EnterpriseLeade ChemoCentryx $CCXI Upgraded at Zacks Investment Research https://t.co/63g1sq25Dj March 14th 2019, 12:03pm |
|
@bibeypost_stock Were Analysts Bearish ChemoCentryx, Inc. $CCXI This Week? https://t.co/VB6JvU32Z0 March 14th 2019, 10:03am |
|
@reurope_stock Can analysts adopt a bullish outlook for ChemoCentryx, Inc. $CCXI? https://t.co/lQfBAvS3vH March 14th 2019, 10:03am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.